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Mutation Altering the miR-184 Seed Region
Causes Familial Keratoconus with Cataract
Anne E. Hughes,1,3,* Declan T. Bradley,1,3 Malcolm Campbell,1 Judith Lechner,2 Durga P. Dash,2
David A. Simpson,2 and Colin E. Willoughby2
MicroRNAs (miRNAs) bind to complementary sequences within the 30 untranslated region (UTR) of mRNAs from hundreds of target
genes, leading either to mRNA degradation or suppression of translation. We found that a mutation in the seed region of miR-184
(MIR184) is responsible for familial severe keratoconus combinedwith early-onset anterior polar cataract by deep sequencing of a linkage
region known to contain the mutation. The mutant form fails to compete with miR-205 (MIR205) for overlapping target sites on the 30
UTRs of INPPL1 and ITGB4. Although these target genes andmiR-205 are expressed widely, the phenotype is restricted to the cornea and
lens because of the very high expression of miR-184 in these tissues. Our finding highlights the tissue specificity of a gene network regu-
lated by a miRNA. Awareness of the important function of miRNAs could aid identification of susceptibility genes and new therapeutic
targets for treatment of both rare and common diseases.Keratoconus (MIM 148300) is a noninflammatory thin-
ning of the central cornea, which results in cone-shaped
protrusion of the cornea, alteration in refractive power,
reduced visual acuity, and image distortion. It is the most
common corneal dystrophy and has an incidence of 1 in
20001 and is a major reason for corneal transplantation.2
Keratoconus is usually inherited as an autosomal-domi-
nant trait with variable expression. Mutations in the visual
system homeobox 1 gene (VSX1 [MIM 605020]) have been
identified in patients with keratoconus; however, their
role in causing disease is controversial.3,4 The pathological
mechanism behind keratoconus is poorly understood, but
evidence points toward dysregulation of apoptosis.5,6
Small (19–25 nucleotide) regulatory strands of RNA,
named microRNAs (miRNAs), bind to complementary
sequences, usually in the 30 untranslated region (UTR) of
mRNA of target genes, leading to degradation of the
mRNA or suppression of translation.7 As part of a RNA-
induced silencing complex, each miRNA might target
mRNA from hundreds of genes.8 Tissue-specific expression
of miRNAs is likely to affect the abundance of proteins in
different organs and their component parts.
Within the eye, miR-184 (encoded by MIR184 [MIM
613146]) is expressed in the central corneal epithelial basal
and suprabasal cells and in the lens epithelium.9,10 In both
tissues it is the most abundant miRNA. MiR-205 is a
widely-expressed epithelial miRNA encoded by MIR205
(MIM 613147). One observed action of miR-184 is the
competitive inhibition of the binding of miR-205 to
mRNA of the inositol polyphosphate phosphatase-like 1
gene (INPPL1, also known as SHIP2 [MIM 600829]).11
Through this mechanism, miR-184 prevents knock-down
by miR-205 and rescues INPPL-1 production. Ultimately,
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regulate apoptosis.11
We investigated the cause of disease in a Northern Irish
family in which 18 of 38 individuals from three genera-
tions were affected by an autosomal-dominant form of
severe anterior keratoconus and early-onset anterior polar
cataract. The study was approved by the Northern Ireland
Office for Research Ethics Committees and conformed to
the tenets of the Declaration of Helsinki. We previously
mapped the disease locus in this family to a 5.5 Mb region
of chromosome 15q22-q25 and excluded many positional
candidate genes by conventional sequencing.12,13
Recently, we enriched for all genes within the region by
sequence capture. A custom sequence capture array (Roche
NimbleGen, Madison, Wisconsin, USA) was designed to
capture 5 Mb of the 5.5 Mb linkage region at 15q22-q25
(a repetitive gene-devoid 0.5 Mb region was excluded).
The array was designed with the Sequence Search and
Alignment by Hashing Algorithm and comprised 385,000
unique probes.14 Three study DNA samples were captured:
one affected family member and two pooled DNA samples
from seven affected and six unaffected family members,
respectively. DNA samples were enriched for the targeted
sequences with the manufacturer’s protocols. Briefly,
21 mg aliquots were fragmented and hybridized to the array
followed by ligation-mediated PCR amplification of the
enriched, fragmented DNA pool. Five micrograms of
amplified enriched DNA underwent massively parallel
sequencing on a Genome Analyzer II (Illumina, San Diego,
CA, USA) with a single sample per flow cell to generate
single-end reads of 40 bp (GATC Biotech, Konstanz, Ger-
many).
Sequence data were converted from Solexa to Sanger
standard format by use of Maq 0.7.1 and aligned to thespital, Grosvenor Road, Belfast BT12 6BN, Northern Ireland, UK; 2Centre for
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Table 1. Annotation of Massively Parallel Sequence
Site of Variant
Coding Gene Noncoding Gene
Total Known Total Known
Coding sequence 9 9 5 4
50 or 30 UTR 12 10 – –
Genetic variants detected in both affected individual and affected pool, but not
in unaffected pool, are categorized by site.
Figure 1. Massively Parallel Sequencing Reads Showing Point
Mutation in MIR184
Multiple alignment of massively parallel sequence reads spanning
the seed region of miR-184 from (A) a single individual affected
with familial keratoconus and cataract, (B) a pool of seven affected
members of the same family and (C) a pool of six unaffected
members of the same family. All nucleotides that vary from the
reference sequence, shown below, are indicated. Read depth and
heterozygosity are designated at the top of each column.National Center for Biotechnology Information v37 refer-
ence sequence with the BWA 0.5.9 short alignment algo-
rithm.15 Sorting, indexing, and removal of duplicates
were performed with Samtools 0.1.14.16 We used Picard
1.43 to edit read groups information. We used functions
of the Genome Analysis Toolkit (GATK)17 to recalibrate
base calls; to realign reads at the sites of possible insertions,
duplications, and deletions; and to call polymorphisms
(Unified Genotyper). Version 130 of dbSNP and the August
4, 2010, release of Dindel data for Europeans from the 1000
Genomes Project were employed for realignment.
VCFtools 0.1.5 was used to compare variant calls from
the three sample groups. The sequence was visualized
with Integrative Genomics Viewer 1.5.18 We used GATK
to annotate the polymorphisms with gene information
from the RefSeq Genes track (made by the genome
sequencing and analysis group at the Broad Institute
from the University of California, Santa Cruz (UCSC)
RefSeq Genes Track, which itself was derived from NCBI
mRNA reference sequences collection; see Web Resources).
Polymorphisms outside gene exons were excluded from
further analyses. All variant calls from the three samples
were entered into a database, which was queried for
instances where the affected individual and the affected
pool shared any genetic variation that was not present in
the unaffected pool. Mean depth of coverage was 23–28
reads in each sample, with 70%–77% having greater than
153 coverage. Twenty-six variants (25 single nucleotide
variants and one deletion of two bases) within exons and
untranslated regions of coding and noncoding genes
were identified that fitted this pattern (Table 1). We
searched dbSNP and the 1000 Genomes Project data
release of May 2011 for these polymorphisms. All but
two SNPs were already known and were identified in Euro-
pean populations at a frequency of greater than 7.5% and
were thus excluded from further consideration. A deletion
of two bases was not recorded in dbSNP or the 1000
Genomes Project. Three possible causative mutations
were therefore identified (Table 2).Table 2. Novel Exonic Variants
Gene Sequence Variant
DNAJA4 g.2099_2100 delAT (NC_000015)
IREB2 c.*2043G>T (NM_004136)
MIR184 r.57c>u (NR_029705)
The AmericanWe searched public databases for information about the
function and expression of MIR184, DNAJA4, and IREB2.
MiR-184 is the most abundantly expressed microRNA in
the corneal and lens epithelia and is known to be involved
in the regulation of protein levels in those tissues.9 The
heterozygous C-to-T transition (r.57c>u) within miR-184
(Figure 1) is in the central nucleotide of the functionally
essential seven base miRNA seed region. DNAJA4 is ex-
pressed in awide range of tissues. Its product is a chaperone
molecule involved in cholesterol biosynthesis.19 The twoJournal of Human Genetics 89, 628–633, November 11, 2011 629
Figure 2. Variants of miR-184 and Conservation across Species, Structure of miR-184, miR-205 andMutant miR-184, and Interactions
of miR-184 and miR-205
(A) Multiple alignment of miR-184 sequences from different vertebrate species. The mutation site (miR-184 r.57c>u, indicated by the
blue arrow) is fully conserved across all species. Changes from the human reference sequence are shown in green type; the mature
miRNAs are shown in red type, and the seed regions are in bold. The following abbreviations are used: hsa, Homo sapiens; ptr, Pan
troglodytes; ppy, Pongo pygmaeus; mne, Macaca nemestrina; mdo, Monodelphis domestica; gga, Gallus gallus; ssc, Sus scrofa; rno, Rattus
norvegicus; mmu, Mus musculus; xtr, Xenopus tropicalis; dre, Danio rerio. Fifty-four additional species showed full conservation of the
mature miR-184 sequence.
(B) Secondary structures and free energies of wild-type miR-184 and mutant miR-184 (r.57u) predicted by Mfold.
(C) Target sites of miR-184 and miR-205 in the 30 UTRs of INPPL1 and ITGB4 predicted by MicroCosm with energies shown in kcal/mol.bases are deleted from the start codon of an alternatively
spliced first exon. The deletion is predicted to prevent
formation of isoform 3 of DNAJA4 from this allele. Rela-
tively little is known about this gene, but it is not known
to have any important role in the eye. IREB2 (MIM
147582) encodes an iron-responsive element-binding
protein that regulates iron metabolism.20 The mutation
in IREB2 in the 30 UTR is not predicted by MicroCosm
Targets to interact with any miRNA.21,22
In light of its role and specific abundance in the cornea
and lens, the mutation altering the seed region of miR-
184 (r.57c>u) was the compelling candidate of the three
previously unknown variants detected within exons. The
gene is conserved in all 65 species known to have a copy
of miR-184 (Figure 2A). We performed conventional
sequencing of MIR184 (Table S1) in 167 unscreened con-
trols and found no mutation within the mature miRNA.
The miR-184 (r.57c>u) mutation was not reported in the
1094 individuals in the 1,000 Genomes Project data
release of May 2011.23 Predictions of RNA folding with
Mfold24 suggest that the mutation does not destabilize
the secondary structure of the mir-184 pre-miR (Figure 2B).
The known competition between miR-184 and miR-205
for the 30 UTR of INPPL1 (Figure 2C) facilitated a rela-
tively straightforward functional assessment for miR-184
(r.57c>u). INPPL1 is expressed constitutively by HeLa cells,
but neither miR-184 nor miR-205 is expressed.25,26 We
used a computational target prediction (the MicroCosm630 The American Journal of Human Genetics 89, 628–633, NovembTargets v.521,22 implementation of the miRanda algo-
rithm27) to search for other instances where miR-184 and
miR-205 had overlapping target sites in a 30 UTR. This
yielded only one other target, integrin beta 4 (ITGB4
[MIM 147557]), which is the main structural protein of
hemidesmosomes that connect corneal basal epithelial
cells to the basement membrane.28
We adapted Yu et al.’s experiment11 to test the ability of
the mutant (r.57u) and wild-type miR-184 to interfere with
the miR-205 knockdown of INPPL1 and ITGB4 transcripts
in HeLa cells by immunohistochemical staining and by
immunoblotting.
Blunt-ended double-strandedmiRNAmimics for the pre-
dominant isoforms of miR-184 and miR-205 (Figure S1,
available online), and for the mutant miR-184 (r.57u)
were synthesized by Invitrogen (Table S2). HeLa cells
(which express INPPL1 and ITGB4 but not miR-184 or
miR-205) were grown to 70% confluence in 24-well plates
in DMEM medium without antibiotics and transfected
with miRNAmimics (20 nmol/L) with Santa Cruz transfec-
tion reagent according to the standard protocol. Cells were
cultured for 72 hr before harvesting for immunoblotting
and staining with anti-INPPL1 (NEBiolabs; no. 2839),
anti-ITGB4 (Abcam; no. 29042) or anti-a-tubulin (Abcam;
no. 4074) at a dilution of 1:1000. Donkey anti-rabbit
and chicken anti-mouse HRP-linked secondary antibodies
were used for immunoblotting and donkey anti-rabbit
FITC-linked secondary antibodies (Abcam) with Alexaer 11, 2011
Figure 3. Immunoblot of INPPL-1 and ITGB4
Knockdown by miRNAs was performed in HeLa cells. Signal
strengths are shown for INPPL-1 and ITGB4 relative to a sham
transfected control, all normalized for a-tubulin loading. One
representative image is shown from five replicated experiments.
(A) There was no rescue of miR-205 knockdown of INPPL-1 by
the mutantmiR-184mimic compared to rescue of miR-205 knock-
down of INPPL-1 by wild-type miR-184 mimic. (B) There was no
rescue of miR-205 knockdown of ITGB4 by the mutant miR-184
mimic compared to rescue of miR-205 knockdown of ITGB4 by
wild-type miR-184 mimic. The error bars represent 95% confi-
dence interval for mean.Fluor-555-labeled phalloidin (Invitrogen) were used for
immunofluorescence. Immunoblots were performed for
five sets of transfections. Luminescence was detected and
quantified with a UVP BioSpectrum AC Imaging System.
Cells from an additional set of transfections were stained
with fluorescently labeled antibodies. Immunofluores-
cence was detected with an Olympus IX51 microscope
and Spot Diagnostics V4.1 (Diagnostic Instruments Inc.)
software. Semiquantitative analysis was carried out on a
minimum of 30 cells for each condition with Adobe Photo-The Americanshop CS3. Statistical analyses were carried out with PASW
statistics v18.0.0 (SPSS Inc., Chicago, IL, USA) and charts
plotted with the gplots package within R v2.10.1.29
The levels of INPPL-1 (Figure 3A) and ITGB4 (Figure 3B)
in HeLa cells in response to transfection with combina-
tions of synthetic miRNAs was measured by immunoblot-
ting. Knockdown of INPPL-1 was minimal with the miR-
184mimic (4.4%; p¼ 0.03) and negligible with themutant
miR-184 mimic (1.8%; p ¼ 0.33). Transfection with the
miR-205 mimic reduced the amount of INPPL-1 detected
to 47% of that in control cells that underwent the process
of transfection without any synthetic miRNA (p ¼ 3.5 3
105). Transfection with the miR-205 mimic in combina-
tion with the wild-type miR-184 mimic resulted in rescue
of levels of INPPL-1 to 86% of controls (p ¼ 2.5 3 103).
However, transfection with the miR-205 mimic in combi-
nation with the mutant miR-184 mimic resulted in failure
to rescue INPPL-1 levels (44% versus 47%; p ¼ 0.57
compared to miR-205 mimic alone).
Knockdown of ITGB4 was moderate with miR-184
mimic (13%; p ¼ 3.4 3 104) and negligible with mutant
miR-184 mimic (3%; p ¼ 0.24). Transfection with miR-
205 mimic reduced the amount of ITGB4 detected to
47% of that in control cells that underwent the process
of transfection without any synthetic miRNA (p ¼ 2.8 3
105). Transfection with miR-205 mimic in combination
with wild-type miR-184 mimic resulted in rescue of levels
of ITGB4 to 80% of controls (p ¼ 4.0 3 103). However,
transfection with miR-205 mimic in combination with
mutant miR-184 mimic resulted in failure to rescue
ITGB4 levels (44% versus 47%; p ¼ 0.50 compared to
miR-205 mimic alone).
Cells transfected with miR-205 mimic combined with
either mutant or wild-type miR-184 mimic were stained
for INPPL-1 and ITGB4. Cells treated with the mutant
miR-184 mimic showed a 37% reduction of INPPL-1
compared to cells treated with the wild-type miR-184
mimic (Figures 4A–4C; p ¼ 1.3 3 104). Cells treated
with the mutant miR-184 mimic showed a 48% reduction
of ITGB4 compared to cells treated with wild-type miR-184
mimic (Figure 4D–4F; p ¼ 7.5 3 106).
The tissue-specific expression of miR-184 is of prime
importance in the phenotypic effects that the mutation
causes. Within the cornea, miR-184 expression is restricted
to central basal and suprabasal epithelial cells,9 under
which the stromal thinning occurs in keratoconus. Within
the lens, the epithelium lies anteriorly and, paralleling the
cornea, has less proliferative capacity centrally.30 This
anterior lens epithelium expresses miR-184,9 adjacent to
the site of the cataract in the affected family.
In the cornea, ITGB4 forms part of the a6b4 heterodimer,
which is the principal component of corneal basal epithe-
lial hemidesmosomes.28 Following corneal injury, hemi-
desmosomes in the basal epithelial layer are degraded to
allow epithelial cellmigration and are subsequently rebuilt.
Expression of miR-184 is halted at the site of corneal injury
and returns after healing.9 Dysregulation of the expressionJournal of Human Genetics 89, 628–633, November 11, 2011 631
Figure 4. Immunofluorescence Staining
of INPPL-1, ITGB4, and Actin
Representative micrographs showing (A
and B) INPPL-1 (green) and actin (red) for
cells transfected with (A) miR-184 mimic
and miR-205 mimic and (B) mutant miR-
184 and miR-205. The scale bar represents
50 mm.
(C) Semiquantitative analysis of mutant
miR-184 knockdown relative to wild-type
miR-184, both in the presence of miR-
205. All measurements were standardized
for actin. The error bars represent 95%
a confidence interval for mean.
Representative micrographs showing (D
and E) ITGB4 (green) and actin (red) for
cells knocked down with (D) miR-184
mimic and miR-205 mimic and (E) mutant
miR-184 and miR-205. The scale bar repre-
sents 50 mm.
(F) Semiquantitative analysis of mutant miR-184 knockdown relative to wild-type miR-184, both with miR-205. All measurements were
standardized for actin. The error bars represent 95% confidence interval for mean.of ITGB4 in the central cornea (the site of miR-184 ex-
pression) might therefore also be important. The stromal
keratocytes underlying the site of an injury undergo rapid
apoptosis as a defense mechanism.6 Therefore, the role of
INPPL-1 in regulation of apoptosis might also be vital in
the development of keratoconus and cataract.
Expression of as many as 1000 genes might be regulated
by miR-184, independently or in competition with other
miRNAs, whichmight lead to complex effects on the levels
of a largenumber of proteins. Theharmful effects ofmutant
miR-184 might be mediated through proteins other than
INPPL-1 and ITGB4. Among the predicted targets of miR-
184 are a major lens transcription factor (FOXE3 [MIM
601094]) and a major intrinsic protein of eye lens fiber
(MIP [MIM 154050]), mutations in both of which cause
lens abnormalities in humans.31 The competition between
miR-184 and miR-205, identified by Yu et al.11 and con-
firmed in our study, illustrates the complexity of miRNA
action. We do not, at present, know why miR-184 is less
effective than miR-205 at knock-down of INPPL-1 and
ITGB4. Further studies are required to illuminate themolec-
ular mechanisms involved.
In some cases, myopia is due to a steeply curving cornea.
A genome-wide association study identified a small region
encompassing MIR184 as a major myopia locus32 and
focused on RASGRF1 (MIM 606600), which is adjacent to
MIR184. Our finding that a MIR184 mutation causes kera-
toconus suggests that this gene warrants further investiga-
tion with respect to myopia.
The role of miRNAs in human diseases and possible
treatments is a new and expanding field of study. This is
the second report of a mutation in a miRNA associated
with a human Mendelian disease. The previous report
identified two mutations in miR-96 that resulted in hered-
itary deafness in two Spanish families.33
Our report demonstrates that variation in miRNAs can
cause disease that is specific to the tissue in which the
miRNA is expressed. This knowledge could open new lines632 The American Journal of Human Genetics 89, 628–633, Novembof enquiry for those investigating the causes of diseases
and could indeed suggest possible treatments: the thera-
peutic use of miRNA in eye diseases is a real and note-
worthy prospect.Supplemental Data
Supplemental Data include one figure and two tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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